Providers see slight increase in COVID vaccine uptake among staff
By
Danielle Brown
May 04, 2021
Long-term care staffers are increasingly opening up to the COVID-19 vaccines, according to the latest insights from the National Investment Center for Seniors Housing & Care (NIC).
Clinical briefs for Monday, June 7
By
Alicia Lasek
Jun 07, 2021
NIC: Nursing homes among ‘safest places’ for seniors following 98% drop in COVID cases … Vaccination is not a risk factor for sudden hearing loss: Johns Hopkins … U.S. population estimate foresees...
Pfizer asks FDA to approve omicron-specific booster shot
Aug 22, 2022
The drug company says that its new mRNA vaccine produces an immune response against the BA.4 and BA.5 omicron subvariants.
Clinical briefs for Wednesday, March 3
By
Alicia Lasek
Mar 03, 2021
Senior living chief medical officer reflects on COVID a year into pandemic, including vaccine acceptance … NIH halts convalescent plasma trial in ED patients with mild COVID symptoms … Stroke patients...
Robust response to virus variants expected in former COVID patients and the vaccinated
By
Alicia Lasek
Mar 31, 2021
Blood samples from recovered COVID-19 patients show that they and their vaccinated peers should be able to fend off the virus and its variants in future encounters, NIH researchers say.
U.S. to test vaccine combos for future anti-variant strategy, Fauci says
By
Alicia Lasek
Apr 01, 2022
The NIH is launching a phase 2 clinical trial to help determine which vaccine combos can provide a broader immune response in adults who have already had a series of COVID-19 vaccinations.
Fauci: ‘Pan-viral’ vaccine may be needed to tackle tenacious COVID-19 long-term
By
Alicia Lasek
Feb 16, 2021
The virus that causes COVID-19 likely is here to stay, and its success in humans means that stronger defense measures will be needed, say Anthony Fauci, M.D., and colleagues from the National Institute...
CDC says COVID-19 vaccine boosters not yet necessary, while Pfizer seeks approval for third dose
By
Alicia Lasek
Jul 12, 2021
Fully vaccinated Americans do not need a COVID-19 booster shot at this time, according to federal health officials. But Pfizer has asked to offer a third dose of its current vaccine and is developing an...
FDA panel recommends second J&J coronavirus vaccine dose for adult recipients
By
Alicia Lasek
Oct 18, 2021
Independent experts have unanimously agreed that a full second dose of the drugmaker’s COVID-19 vaccine be offered to adults aged 18 years and older at least two months after receipt of the first...
FDA may authorize half-dose booster of Moderna’s coronavirus vaccine
By
Alicia Lasek
Sep 30, 2021
A 50-microgram dose appears to be effective enough to increase waning vaccine protection, and may reduce the risk of side effects, sources tell investigators.